Conference abstract · 31 Aug 2020
Mini reviewPublished 2015
Is It Right Time to Construct New Radiopharmaceutical Development Strategies?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Guldem Mercanoglu and Yekta Ozer PDF Share this article
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Letter · 2014
Pharmaceutical Equivalence and Bioequivalence of Radiopharmaceuticals: Thinking the Possibility of Generic Radiopharmaceuticals and Preparing for New Technology as Nanotechnology Drugs
Editorial · 20 Jun 2012
The Climate is Right to Accelerate New Drug Development for Neglected Diseases
Perspective · 29 Dec 2023
Advancements in Radiopharmaceutical Development for Diagnostic Imaging
Conference abstract · 28 Nov 2016
Elimination of measles through routine vaccination in India (and other developing countries): Time to deliver old wine in a new bottle
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Guldem Mercanoglu”
- BylineArticles whose byline prints “Yekta Ozer”

